The role of cellular senescence in bone loss and recovery in periodontal disease
细胞衰老在牙周病骨质流失和恢复中的作用
基本信息
- 批准号:10741898
- 负责人:
- 金额:$ 15.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAdverse effectsAgeAge-Related Bone LossAgingAlveolar Bone LossAttenuatedBiologicalBiological AssayBiologyBone ResorptionCell AgingCellsClinical TrialsDevelopmentDiseaseDisease modelExcisionFoundationsFutureGenesGingivaGoalsHumanImmunohistochemistryInduction of ApoptosisInflammationLifeLigatureMandibleMature BoneMeasurementMechanicsMediatorMusMusculoskeletalOsteoclastsOsteogenesisOutcomeOutcome StudyPathologicPathologyPatientsPeriodontal DiseasesPeriodontal LigamentPharmaceutical PreparationsPhenotypePlayPredispositionPrevalencePrevention strategyPublic HealthRecoveryRoleTestingTherapeutic InterventionTissuesTooth CervixTooth LossTooth structureWorkage relatedalternative treatmentalveolar bonebonebone lossclinical efficacyconventional therapyexperimental studyfisetinimprovednovel therapeuticsphenotypic biomarkerpreventsenescencestressortelomeretherapeutically effectivetreatment strategy
项目摘要
Project Summary/Abstract
The prevalence of tooth-supporting alveolar bone loss by periodontal disease (PD) steeply rises in the 3rd
and 4th decades of life. As such, PD is a leading cause of tooth loss in adults. Mechanisms behind the increased
susceptibility to PD bone loss in adulthood are unknown. 17 to 23% of PD patients do not respond to current
treatment and thus progress to tooth loss. Our long-term goal is to identify the mechanism of age-related bone
loss in PD to develop mechanistically based therapies of PD bone loss. A potential factor in the development
of PD bone loss is the accumulation of senescent cells. Senescent cell accumulation in tissues is increasingly
recognized as a driver of age-associated disorders. To mitigate the deleterious effects, senescent cells can be
removed by drugs called senolytics that selectively induce apoptosis in senescent cells. Fisetin is a recently
characterized senolytic without observable adverse effects and is being evaluated in clinical trials targeting
pathological conditions hallmarked by senescent cell burden.
Our preliminary studies using the ligature-induced PD (LIP) model showed that LIP induces initial rapid
bone resorption followed by a rapid recovery due to bone formation by day 14 in young mice (2.5 months). In
contrast, significant bone loss remained at day 14 in mature mice (8-12 months). Also, mature mice showed
greater bone volume loss compared to young mice, indicating the increased susceptibility to LIP-induced bone
loss in mature mice. Furthermore, bone formation rate in mature mice with LIP was lower than young mice,
suggesting that diminished bone formation rate is responsible for the increased susceptibility to LIP-induced
bone loss in mature mice. We found increases in expression levels of senescence marker genes in periodontal
tissue of mature mice before PD induction, suggesting that accumulation of senescent cells in the tissue
increase the susceptibility to LIP-induced bone loss in mature mice. Our hypothesis is that accumulation of
the senescent cells is a critical factor responsible for inhibiting bone recovery and for increasing bone loss
susceptibility in the pathology of PD bone loss, and that senolytic treatment will improves the PD-driven bone
loss. Here, we propose the following aims: Specific Aim 1: Determine if the clearance of pre-existing
senescent cells by the senolytic, fisetin, will prevent PD alveolar bone loss. 12-month-old mice will be pre-
treated with fisetin to clear and prevent age-related senescent accumulation before inducing LIP, and we will
analyze the effect of senescent cell clearance by fisetin pre-treatment on LIP-induced bone loss. Specific Aim
2: Determine if fisetin treatment will induce recovery from PD-induced bone loss. We will induce LIP in 12-
months-old mice and wait until bone resorption progress to detectable levels before starting fisetin treatment.
We will then analyze bone loss induced by LIP. Our team is uniquely suited to conduct these experiments with
expertise in periodontology, bone biology, and cellular senescence in musculoskeletal tissue. Outcomes from
this work will lead us to further mechanistic studies of the role of senescence in PD toward our long-term goal.
项目概要/摘要
牙周病(PD)导致牙齿支持牙槽骨丧失的患病率在第三个世纪急剧上升
和人生的第四个十年。因此,PD 是成人牙齿脱落的主要原因。增长背后的机制
成年期对 PD 骨丢失的易感性尚不清楚。 17% 至 23% 的 PD 患者对当前的治疗没有反应
治疗,从而导致牙齿脱落。我们的长期目标是确定与年龄相关的骨骼的机制
开发基于机制的 PD 骨丢失疗法。发展的潜在因素
PD骨质流失的主要原因是衰老细胞的积累。衰老细胞在组织中的积累越来越多
被认为是与年龄相关的疾病的驱动因素。为了减轻有害影响,可以将衰老细胞
被称为 senolytics 的药物去除,选择性诱导衰老细胞凋亡。非瑟酮是最近
senolytic 的特点是没有可观察到的副作用,并且正在针对目标的临床试验中进行评估
以衰老细胞负担为特征的病理状况。
我们使用结扎诱导 PD (LIP) 模型进行的初步研究表明,LIP 诱导初始快速
年轻小鼠(2.5 个月)的骨吸收随后因骨形成而迅速恢复,并在第 14 天时出现。在
相比之下,成熟小鼠(8-12 个月)在第 14 天仍存在明显的骨质流失。此外,成熟小鼠还表现出
与年轻小鼠相比,骨量损失更大,表明对 LIP 诱导的骨的敏感性增加
成熟小鼠的损失。此外,患有 LIP 的成熟小鼠的骨形成率低于年轻小鼠,
表明骨形成率降低是 LIP 诱导的易感性增加的原因
成熟小鼠的骨质流失。我们发现牙周衰老标志基因的表达水平增加
PD诱导前成熟小鼠的组织,表明组织中衰老细胞的积累
增加成熟小鼠对 LIP 诱导的骨质流失的敏感性。我们的假设是,积累
衰老细胞是抑制骨质恢复和增加骨质流失的关键因素
PD 骨质流失病理学的易感性,并且 senolytic 治疗将改善 PD 驱动的骨质流失
损失。在此,我们提出以下目标: 具体目标 1:确定是否清除现有的
衰老细胞中的senolytic、fisetin,将防止PD牙槽骨丢失。 12个月大的小鼠将被预先
在诱导 LIP 之前用非瑟酮处理以清除和预防与年龄相关的衰老积累,我们将
分析非瑟酮预处理清除衰老细胞对 LIP 诱导的骨丢失的影响。具体目标
2:确定非瑟酮治疗是否会促使 PD 引起的骨质流失恢复。我们将在 12 年内诱导 LIP
几个月大的小鼠,等到骨吸收进展到可检测的水平,然后开始非瑟酮治疗。
然后我们将分析 LIP 引起的骨质流失。我们的团队非常适合进行这些实验
牙周病学、骨生物学和肌肉骨骼组织细胞衰老方面的专业知识。结果来自
这项工作将引导我们进一步研究衰老在帕金森病中的作用,以实现我们的长期目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mizuho Kittaka其他文献
Mizuho Kittaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 15.85万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 15.85万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 15.85万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 15.85万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 15.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 15.85万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 15.85万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 15.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 15.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 15.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




